Last Price$63.3(0.2%)
Market Cap$14.7B
LTM Operating Income margin
23.9%
5Y avg
27.3%
Medical - Instruments & Supplies industry
median
(4.8%)
Stock quality & Intrinsic value
7/10
1.1% undervalued
Hologic, Inc. Operating Income margin
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Sep'05 | Sep'06 | Sep'07 | Sep'08 | Sep'09 | Sep'10 | Sep'11 | Sep'12 | Sep'13 | Sep'14 | Sep'15 | Sep'16 | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income margin | 11.3% | 10.9% | 20.0% | (11.8%) | (123.2%) | 4.2% | 20.9% | 5.7% | (36.4%) | 11.1% | 16.8% | 19.4% | 44.8% | (7.4%) | 4.0% | 29.3% | 44.0% | 33.7% | 16.6% | 21.9% |
Overvalued or undervalued?
Check the intrinsic value for HOLX
and see if it's the right time to invest.
Hologic, Inc. (HOLX) Operating Income margin comparison analysis
General
LTM Operating Income margin
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Hologic, Inc.HOLX
23.9%
(0.0%)
81.1%
19.6%
Median Peer Set
14.2%
3.4%
15.9%
10.2%
ResMed Inc.RMD
31.7%
10.9%
13.4%
21.8%
Intuitive Surgical, Inc.ISRG
28.1%
17.2%
27.7%
27.8%
West Pharmaceutical Services, Inc.WST
19.9%
(1.9%)
(15.5%)
17.0%
The Cooper Companies, Inc.COO
18.1%
8.4%
32.2%
10.1%
Alcon Inc.ALC
14.2%
8.5%
182.9%
10.3%
AptarGroup, Inc.ATR
14.1%
2.7%
30.2%
10.5%
Becton, Dickinson and CompanyBDX
12.9%
4.2%
18.3%
8.4%
Repligen CorporationRGEN
(0.8%)
(21.1%)
(80.9%)
5.6%
Baxter International Inc.BAX
(1.1%)
(69.5%)
(100.0%)
(6.9%)
Masimo CorporationMASI
(12.7%)
0.6%
(42.5%)
4.0%
HOLX key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Sep'05 | Sep'06 | Sep'07 | Sep'08 | Sep'09 | Sep'10 | Sep'11 | Sep'12 | Sep'13 | Sep'14 | Sep'15 | Sep'16 | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 287.7 25.8% | 462.7 60.8% | 738.4 59.6% | 1,674.5 126.8% | 1,637.1 (2.2%) | 1,679.6 2.6% | 1,789.3 6.5% | 2,002.7 11.9% | 2,492.3 24.4% | 2,530.7 1.5% | 2,705.0 6.9% | 2,832.7 4.7% | 3,058.8 8.0% | 3,217.9 5.2% | 3,367.3 4.6% | 3,776.4 12.1% | 5,632.3 49.1% | 4,862.8 (13.7%) | 4,030.4 (17.1%) | 4,030.3 (0.0%) |
| Cost of Goods Sold (COGS) | 174.7 | 269.1 | 392.8 | 782.0 | 779.6 | 942.9 | 866.2 | 1,008.2 | 1,330.9 | 1,285.2 | 1,272.3 | 1,269.4 | 1,437.8 | 1,521.2 | 2,059.2 | 1,548.9 | 1,836.5 | 1,865.4 | 1,958.9 | 1,802.5 |
% margin | 113.0 39.3% | 193.5 41.8% | 345.6 46.8% | 892.5 53.3% | 857.5 52.4% | 736.6 43.9% | 923.2 51.6% | 994.4 49.7% | 1,161.4 46.6% | 1,245.5 49.2% | 1,432.7 53.0% | 1,563.3 55.2% | 1,621.0 53.0% | 1,696.7 52.7% | 1,308.1 38.8% | 2,227.5 59.0% | 3,795.8 67.4% | 2,997.4 61.6% | 2,071.5 51.4% | 2,227.8 55.3% |
| Operating Expenses | 80.4 | 123.3 | 197.8 | 518.5 | 533.3 | 566.3 | 536.1 | 745.8 | 880.1 | 908.5 | 949.1 | 1,004.2 | 1,137.2 | 1,188.7 | 1,181.4 | 1,102.8 | 1,312.9 | 1,366.6 | 1,310.0 | 1,345.2 |
| Research & Development Expenses (R&D) | 18.6 | 28.3 | 44.5 | 81.4 | 94.3 | 104.3 | 116.7 | 131.0 | 197.6 | 203.2 | 214.9 | 232.1 | 232.8 | 218.7 | 232.2 | 222.5 | 276.3 | 283.4 | 294.3 | 272.8 |
| Selling, General & Administrative Expenses (SG&A) | 61.8 | 98.5 | 147.7 | 408.9 | 387.8 | 407.1 | 445.5 | 542.4 | 569.8 | 591.5 | 624.0 | 682.4 | 841.9 | 910.7 | 897.2 | 840.6 | 994.4 | 1,038.0 | 987.6 | 994.8 |
% margin | 32.6 11.3% | 50.3 10.9% | 147.8 20.0% | (197.5) (11.8%) | (2,016.7) (123.2%) | 69.9 4.2% | 374.4 20.9% | 113.7 5.7% | (906.3) (36.4%) | 279.7 11.1% | 455.1 16.8% | 548.6 19.4% | 1,370.2 44.8% | (237.9) (7.4%) | 134.4 4.0% | 1,105.0 29.3% | 2,480.3 44.0% | 1,640.2 33.7% | 668.4 16.6% | 882.6 21.9% |
| Interest Income | 0.0 | 0.0 | 0.0 | 4.5 | 1.2 | 1.3 | 1.9 | 2.3 | 1.3 | 1.3 | 1.3 | 0.7 | 3.8 | 6.3 | 4.6 | 4.3 | 1.4 | 12.9 | 120.5 | 108.7 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 84.9 | 73.2 | 126.2 | 114.8 | 140.3 | 281.1 | 220.6 | 205.5 | 155.3 | 153.2 | 148.7 | 140.8 | 116.5 | 93.6 | 95.1 | 111.1 | 122.1 |
| Pre-tax Income | 34.7 | 53.2 | 148.5 | (279.1) | (2,088.7) | (55.0) | 227.4 | (61.7) | (1,193.0) | 48.1 | 177.2 | 415.3 | 1,230.5 | (418.6) | (95.3) | 1,001.9 | 2,361.1 | 1,588.2 | 676.1 | 865.1 |
% effective tax rate | 6.4 18.6% | 25.8 48.5% | 53.9 36.3% | 106.5 (38.1%) | 87.6 (4.2%) | 7.8 (14.2%) | 70.2 30.9% | 12.0 (19.4%) | (20.1) 1.7% | 30.8 64.0% | 45.6 25.7% | 84.5 20.3% | 475.0 38.6% | (307.3) 73.4% | (55.1) 57.8% | (108.6) (10.8%) | 491.4 20.8% | 286.2 18.0% | 220.1 32.6% | 75.6 8.7% |
% margin | 28.3 9.8% | 27.4 5.9% | 94.6 12.8% | (385.6) (23.0%) | (2,176.2) (132.9%) | (62.8) (3.7%) | 157.2 8.8% | (73.6) (3.7%) | (1,172.8) (47.1%) | 17.3 0.7% | 131.6 4.9% | 330.8 11.7% | 755.5 24.7% | (111.3) (3.5%) | (40.2) (1.2%) | 1,115.2 29.5% | 1,871.5 33.2% | 1,302.0 26.8% | 456.0 11.3% | 789.5 19.6% |
| EPS | 0.33 | 0.30 | 0.88 | (1.57) | (8.48) | (0.24) | 0.60 | (0.28) | (4.36) | 0.06 | 0.47 | 1.18 | 2.70 | (0.40) | (0.15) | 4.24 | 7.28 | 5.18 | 1.85 | 3.35 |
| Diluted EPS | 0.32 | 0.28 | 0.86 | (1.57) | (8.48) | (0.24) | 0.59 | (0.28) | (4.36) | 0.06 | 0.45 | 1.16 | 2.64 | (0.40) | (0.15) | 4.21 | 7.21 | 5.13 | 1.83 | 3.32 |
% margin | 40.2 14.0% | 70.6 15.2% | 178.9 24.2% | (21.3) (1.3%) | (1,745.2) (106.6%) | 366.9 21.8% | 647.0 36.2% | 424.4 21.2% | (395.9) (15.9%) | 791.9 31.3% | 874.1 32.3% | 1,036.0 36.6% | 1,832.9 59.9% | 210.4 6.5% | 346.1 10.3% | 1,496.7 39.6% | 2,861.6 50.8% | 2,113.4 43.5% | 1,110.6 27.6% | 1,296.2 32.2% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Hologic, Inc.'s Operating Income margin?
As of today, Microsoft Corp's last 12-month Operating Income margin is 23.9%, based on the financial report for Dec 28, 2024 (Q4’2024). The average annual Operating Income margin for Hologic, Inc. have been 28.2% over the past three years, and 28.7% over the past five years.
2) Is Hologic, Inc.'s Operating Income margin Good?
As of today, Hologic, Inc.'s Operating Income margin is 23.9%, which is higher than industry median of (4.8%). It indicates that Hologic, Inc.'s Operating Income margin is Good.